Jane Street
AVXL icon

Jane Street’s Anavex Life Sciences AVXL Stock Holding History

Jane Street’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-24,700
Closed -$87.9K – 11551
2025
Q4 		$87.9K Buy
+24,700
New +$151K ﹤0.01% 10245
2024
Q2 		– Sell
-26,100
Closed -$133K – 9336
2024
Q1 		$133K Sell
26,100
-62,900
-71% -$354K ﹤0.01% 8413
2023
Q4 		$829K Buy
89,000
+58,000
+187% +$399K ﹤0.01% 5897
2023
Q3 		$203K Buy
31,000
+14,700
+90% +$117K ﹤0.01% 7601
2023
Q2 		$133K Buy
16,300
+4,000
+33% +$34.3K ﹤0.01% 7873
2023
Q1 		$105K Sell
12,300
-53,200
-81% -$531K ﹤0.01% 8203
2022
Q4 		$607K Buy
65,500
+10,500
+19% +$112K ﹤0.01% 5799
2022
Q3 		$568K Buy
55,000
+700
+1% +$7.39K ﹤0.01% 6453
2022
Q2 		$544K Sell
54,300
-69,600
-56% -$659K ﹤0.01% 6584
2022
Q1 		$1.52M Sell
123,900
-16,900
-12% -$208K ﹤0.01% 5271
2021
Q4 		$2.44M Sell
140,800
-88,000
-38% -$1.67M ﹤0.01% 4071
2021
Q3 		$4.11M Sell
228,800
-96,500
-30% -$1.92M ﹤0.01% 3066
2021
Q2 		$7.44M Buy
325,300
+287,200
+754% +$4.25M ﹤0.01% 2073
2021
Q1 		$570K Buy
+38,100
New +$416K ﹤0.01% 6562

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Jane Street's AVXL Position: Q1 2026 in Review

Jane Street reduced its Anavex Life Sciences (AVXL) stake by 5.7% in Q1 2026, selling an estimated $190K and leaving 725,003 shares worth $2.23M. The position accounts for ﹤0.01% of the portfolio, ranked #4879.

Jane Street first reported a position in AVXL in Q4 2015 and has held it in 27 quarters since. The position peaked at $4.7M in Q2 2021. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

  • Jane Street held 725,003 shares of Anavex Life Sciences worth $2.23M as of Q1 2026.
  • Jane Street sold 43,952 Anavex Life Sciences shares in Q1 2026, an estimated $190K.
  • Anavex Life Sciences made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #4879 holding.
  • Jane Street first reported a position in Anavex Life Sciences in Q4 2015 and has held it in 27 quarters since.
  • Jane Street's Anavex Life Sciences position peaked at $4.7M in Q2 2021.
  • 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.